SciELO - Scientific Electronic Library Online

 
vol.110 issue11Topical mesalazine as a cause of Stevens-Johnson syndrome author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Española de Enfermedades Digestivas

Print version ISSN 1130-0108

Abstract

MORA, Lorena et al. Treatment of graft-versus-host disease with mesenchymal cells as a complication of a liver transplantation. Rev. esp. enferm. dig. [online]. 2018, vol.110, n.11, pp.734-736. ISSN 1130-0108.  https://dx.doi.org/10.17235/reed.2018.5672/2018.

We present the case of a liver transplant (LT) recipient donor who developed graft versus host disease (GVHD). The main features were cutaneous rash, diarrhea and pancytopenia. Mesenchymal cells were administered as part of the treatment. This is the first case of a patient with GVHD after LT reported to date. Despite the treatment, there was no improvement in aplasia or gastrointestinal symptoms and the patient died due to a disseminated infection.

Keywords : Orthotopic liver transplantation; Graft versus host disease; Mesenchymal cells.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )